IBDEI0U8 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30396,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,30396,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,30397,0)
 ;;=F16.959^^113^1466^9
 ;;^UTILITY(U,$J,358.3,30397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30397,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,30397,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,30397,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,30398,0)
 ;;=F16.99^^113^1466^38
 ;;^UTILITY(U,$J,358.3,30398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30398,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,30398,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,30398,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,30399,0)
 ;;=F16.983^^113^1466^16
 ;;^UTILITY(U,$J,358.3,30399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30399,1,3,0)
 ;;=3^Hallucinogen Persisting Perception Disorder
 ;;^UTILITY(U,$J,358.3,30399,1,4,0)
 ;;=4^F16.983
 ;;^UTILITY(U,$J,358.3,30399,2)
 ;;=^5003358
 ;;^UTILITY(U,$J,358.3,30400,0)
 ;;=F16.20^^113^1466^37
 ;;^UTILITY(U,$J,358.3,30400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30400,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Severe
 ;;^UTILITY(U,$J,358.3,30400,1,4,0)
 ;;=4^F16.20
 ;;^UTILITY(U,$J,358.3,30400,2)
 ;;=^5003336
 ;;^UTILITY(U,$J,358.3,30401,0)
 ;;=F16.180^^113^1466^17
 ;;^UTILITY(U,$J,358.3,30401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30401,1,3,0)
 ;;=3^Phencyclidine Induced Anxiety Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,30401,1,4,0)
 ;;=4^F16.180
 ;;^UTILITY(U,$J,358.3,30401,2)
 ;;=^5003332
 ;;^UTILITY(U,$J,358.3,30402,0)
 ;;=F16.280^^113^1466^18
 ;;^UTILITY(U,$J,358.3,30402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30402,1,3,0)
 ;;=3^Phencyclidine Induced Anxiety Disorder w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,30402,1,4,0)
 ;;=4^F16.280
 ;;^UTILITY(U,$J,358.3,30402,2)
 ;;=^5003345
 ;;^UTILITY(U,$J,358.3,30403,0)
 ;;=F16.980^^113^1466^19
 ;;^UTILITY(U,$J,358.3,30403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30403,1,3,0)
 ;;=3^Phencyclidine Induced Anxiety Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,30403,1,4,0)
 ;;=4^F16.980
 ;;^UTILITY(U,$J,358.3,30403,2)
 ;;=^5003357
 ;;^UTILITY(U,$J,358.3,30404,0)
 ;;=F16.14^^113^1466^20
 ;;^UTILITY(U,$J,358.3,30404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30404,1,3,0)
 ;;=3^Phencyclidine Induced Bipolar & Related Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,30404,1,4,0)
 ;;=4^F16.14
 ;;^UTILITY(U,$J,358.3,30404,2)
 ;;=^5003328
 ;;^UTILITY(U,$J,358.3,30405,0)
 ;;=F16.24^^113^1466^21
 ;;^UTILITY(U,$J,358.3,30405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30405,1,3,0)
 ;;=3^Phencyclidine Induced Bipolar & Related Disorder w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,30405,1,4,0)
 ;;=4^F16.24
 ;;^UTILITY(U,$J,358.3,30405,2)
 ;;=^5003341
 ;;^UTILITY(U,$J,358.3,30406,0)
 ;;=F16.94^^113^1466^22
 ;;^UTILITY(U,$J,358.3,30406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30406,1,3,0)
 ;;=3^Phencyclidine Induced Bipolar & Related Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,30406,1,4,0)
 ;;=4^F16.94
 ;;^UTILITY(U,$J,358.3,30406,2)
 ;;=^5003353
 ;;^UTILITY(U,$J,358.3,30407,0)
 ;;=F16.14^^113^1466^23
 ;;^UTILITY(U,$J,358.3,30407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30407,1,3,0)
 ;;=3^Phencyclidine Induced Depressive Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,30407,1,4,0)
 ;;=4^F16.14
 ;;^UTILITY(U,$J,358.3,30407,2)
 ;;=^5003328
 ;;^UTILITY(U,$J,358.3,30408,0)
 ;;=F16.24^^113^1466^24
 ;;^UTILITY(U,$J,358.3,30408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30408,1,3,0)
 ;;=3^Phencyclidine Induced Depressive Disorder w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,30408,1,4,0)
 ;;=4^F16.24
 ;;^UTILITY(U,$J,358.3,30408,2)
 ;;=^5003341
 ;;^UTILITY(U,$J,358.3,30409,0)
 ;;=F16.94^^113^1466^25
 ;;^UTILITY(U,$J,358.3,30409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30409,1,3,0)
 ;;=3^Phencyclidine Induced Depressive Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,30409,1,4,0)
 ;;=4^F16.94
 ;;^UTILITY(U,$J,358.3,30409,2)
 ;;=^5003353
 ;;^UTILITY(U,$J,358.3,30410,0)
 ;;=F16.159^^113^1466^26
 ;;^UTILITY(U,$J,358.3,30410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30410,1,3,0)
 ;;=3^Phencyclidine Induced Psychotic Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,30410,1,4,0)
 ;;=4^F16.159
 ;;^UTILITY(U,$J,358.3,30410,2)
 ;;=^5003331
 ;;^UTILITY(U,$J,358.3,30411,0)
 ;;=F16.259^^113^1466^27
 ;;^UTILITY(U,$J,358.3,30411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30411,1,3,0)
 ;;=3^Phencyclidine Induced Psychotic Disorder w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,30411,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,30411,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,30412,0)
 ;;=F16.959^^113^1466^28
 ;;^UTILITY(U,$J,358.3,30412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30412,1,3,0)
 ;;=3^Phencyclidine Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,30412,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,30412,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,30413,0)
 ;;=F16.129^^113^1466^32
 ;;^UTILITY(U,$J,358.3,30413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30413,1,3,0)
 ;;=3^Phencyclidine Intoxication w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,30413,1,4,0)
 ;;=4^F16.129
 ;;^UTILITY(U,$J,358.3,30413,2)
 ;;=^5003327
 ;;^UTILITY(U,$J,358.3,30414,0)
 ;;=F16.229^^113^1466^33
 ;;^UTILITY(U,$J,358.3,30414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30414,1,3,0)
 ;;=3^Phencyclidine Intoxication w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,30414,1,4,0)
 ;;=4^F16.229
 ;;^UTILITY(U,$J,358.3,30414,2)
 ;;=^5003340
 ;;^UTILITY(U,$J,358.3,30415,0)
 ;;=F16.929^^113^1466^34
 ;;^UTILITY(U,$J,358.3,30415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30415,1,3,0)
 ;;=3^Phencyclidine Intoxication w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,30415,1,4,0)
 ;;=4^F16.929
 ;;^UTILITY(U,$J,358.3,30415,2)
 ;;=^5003352
 ;;^UTILITY(U,$J,358.3,30416,0)
 ;;=F16.121^^113^1466^29
 ;;^UTILITY(U,$J,358.3,30416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30416,1,3,0)
 ;;=3^Phencyclidine Intoxication Delirium w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,30416,1,4,0)
 ;;=4^F16.121
 ;;^UTILITY(U,$J,358.3,30416,2)
 ;;=^5003325
 ;;^UTILITY(U,$J,358.3,30417,0)
 ;;=F16.221^^113^1466^30
 ;;^UTILITY(U,$J,358.3,30417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30417,1,3,0)
 ;;=3^Phencyclidine Intoxication Delirium w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,30417,1,4,0)
 ;;=4^F16.221
 ;;^UTILITY(U,$J,358.3,30417,2)
 ;;=^5003339
 ;;^UTILITY(U,$J,358.3,30418,0)
 ;;=F16.921^^113^1466^31
 ;;^UTILITY(U,$J,358.3,30418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30418,1,3,0)
 ;;=3^Phencyclidine Intoxication Delirium w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,30418,1,4,0)
 ;;=4^F16.921
 ;;^UTILITY(U,$J,358.3,30418,2)
 ;;=^5003351
 ;;^UTILITY(U,$J,358.3,30419,0)
 ;;=F11.10^^113^1467^24
 ;;^UTILITY(U,$J,358.3,30419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30419,1,3,0)
 ;;=3^Opioid Use Disorder,Mild
 ;;^UTILITY(U,$J,358.3,30419,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,30419,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,30420,0)
 ;;=F11.129^^113^1467^20
 ;;^UTILITY(U,$J,358.3,30420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30420,1,3,0)
 ;;=3^Opioid Intoxication w/o Perceptual Disturbances w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,30420,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,30420,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,30421,0)
 ;;=F11.14^^113^1467^5
 ;;^UTILITY(U,$J,358.3,30421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30421,1,3,0)
 ;;=3^Opioid Induced Depressive Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,30421,1,4,0)
 ;;=4^F11.14
 ;;^UTILITY(U,$J,358.3,30421,2)
 ;;=^5003119
 ;;^UTILITY(U,$J,358.3,30422,0)
 ;;=F11.182^^113^1467^11
